Targeting CLL-1 for acute myeloid leukemia therapy

Targeting CLL-1 for acute myeloid leukemia therapy

Abstract Despite major scientific discoveries and novel therapies over the past four decades, the treatment outcomes of acute myeloid leukemia (AML), especially in the adult patient population remain dismal. In the past few years, an increasing number of targets such as CD33, CD123, CLL-1, CD47, CD7...

Full description

Bibliographic Details
Main Authors: Hongbing Ma, Iyer Swaminathan Padmanabhan, Simrit Parmar, Yuping Gong
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Journal of Hematology & Oncology
Subjects:
Acute myeloid leukemia
CLL-1
CLEC12A
DCAL-2
hMICL
CD371
Online Access:http://link.springer.com/article/10.1186/s13045-019-0726-5

Internet

http://link.springer.com/article/10.1186/s13045-019-0726-5

Similar Items